News | May 05, 2022
Promising new universal coronavirus vaccine candidate discovered
Formula attenuates 99% of 365 coronaviruses in computer models
Formula attenuates 99% of 365 coronaviruses in computer models
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers
Subscribe To Our Newsletter & Stay Updated
